Skip to main content
. 2000 Nov 15;28(22):4410–4418. doi: 10.1093/nar/28.22.4410

Figure 2.

Figure 2

cyclin B2 mRNA levels decrease upon treatment with chemotherapeutics in p53-positive cells. The same samples from HepG2 cells as used in Figure 1 were analysed with the LightCycler system for their change in cyclin B2 mRNA concentration. Expression levels were normalised to GAPDH mRNA levels. For a detailed description of calculations see Materials and Methods.